HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea · Delayed Price · Currency is KRW 4,520.00
+335.00 (8.00%)
Oct 8, 2026, 3:30 PM KST
HLB Life Science Market Cap
HLB Life Science has a market cap or net worth of 550.75 billion as of October 8, 2026. It is the 16,183rd most valuable company in the world and the 449th biggest in South Korea. Its market cap has increased by 37.80% in one year.
Market Cap
550.75B
Enterprise Value
695.82B
Revenue
54.40B
Global Rank
Country Rank
#449 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2008, HLB Life Science's market cap has increased from 12.28B to 550.75B, an increase of 4,383.94%. That is a compound annual growth rate of 23.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 550.75B | 16.65% |
| Dec 30, 2025 | 472.16B | -61.28% |
| Dec 30, 2024 | 1.22T | 4.61% |
| Dec 28, 2023 | 1.17T | 8.14% |
| Dec 29, 2022 | 1.08T | -9.34% |
| Dec 30, 2021 | 1.19T | -7.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.37T |
| Celltrion | 41.03T |
| ALTEOGEN | 16.78T |
| Samsung Epis Holdings | 8.46T |
| Dong-A Socio Holdings | 625.88B |
| Myung In Pharmaceutical LTD. | 621.23B |
| JW Pharmaceutical | 601.57B |
| GI Innovation | 545.81B |